News about Biotechnology, Pharmaceutical and Healthcare

23:05 EST 25th November 2014 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 9,700+

Tuesday 25th November 2014

Finance Yorkshire boosts life sciences business

Finance Yorkshire’s successful track record for investing in early stage businesses continues with the AIM listing of another of its investee companies.Based in York, OptiBiotix Health is developing products to tackle obesity, high cholesterol ...

North West Director of the Year Awards 2015

This year with a new Science and Innovation category, these Awards celebrate the very best this region has to offer in business. Winning one of these Awards shows that you have been recognised as the best in your field by the organisation for busines...

Model 360 Flame Photometer delivers all-round excellence!

A five-element instrument from Sherwood Scientific brings unrivalled precision, ergonomic design and ease of maintenance to the market for low-cost industrial flame photometers. As a world-leader in flame photometry Sherwood Scientific is renowned for developing instruments with the highest levels of stability and reliability. The Model 360 is a single channel unit built around the very same mixi...

Simplifying SPR experiments with the HP D300 from Tecan

The Structure and Biophysics department at AstraZeneca R&D Mölndal, Sweden, is reaping the benefits of a recently acquired HP D300 Digital Dispenser for surface plasmon resonance (SPR) studies, saving time, enhancing consistency and using significantly less compound for dose-response experiments. Principal Scientist Stefan Geschwindner explained: “The need for the HP D300 Digital Di...

Lundbeck chief executive resigns amid scandal

Ulf Wiinberg has resigned from his chief executive post at Denmark-based pharma giant Lundbeck following a beach of its rules relating to shares. Håkan Björklund will be chairman of the board with extended operational responsibilities for the firm, and will act as the day-to-day leader as it searches for a chief executive replacement. In 2013 Wiinberg omitted to request and obtain prior approval...

JULABO Cryo-Compact Circulators

Maximum Performance – Minimum Space When space is scarce but routine applications require high performance, then the answer is JULABO Cryo-Compact Circulators. JULABO presents the compact cooling circulators of the CF series with working temperatures ranging from -40 °C to +200 °C. These units can be installed in the tightest of spaces or inside of technical applications. All models...


J. G. Finneran Associates is pleased to announce the addition of QuEChers to their product offerings.  QuEChERS  (pronounced “catchers”), is an acronym for Quick, Easy, Cheap, Effective, Rugged and Safe. QuEChERS offer a convenient and effective sample preparation technique for determining pesticide residues in fruit, vegetables and other foods. Finneran QuEChERS make it simp...

Immersion Coolers for Flexible Cooling Down to -100 °C

With their range of Immersion Coolers, Huber Kältemaschinenbau offers a flexible solution for a variety of cooling applications. These units are easy to use and ideally suited to quick liquid cooling. A typical application is to cool heating thermostats or as a substitute for dry ice. Immersion coolers offer an environmentally friendly cooling alternative by reducing consumption of tap water...

Are you reaching the limit with manual multichannel pipettes?

INTEGRA offer an efficient way to increase sample throughput without the expense of a robotic system. The VIAFLO 96 benchtop electronic pipette offers an affordable solution to increase productivity when working with microplates. It closes the gap between traditional manual pipettes and robotic systems, allowing for accurate and reproducible 96-channel pipetting. The VIAFLO 384 is a more adv...

Monday 24th November 2014

Too much of a good thing: Excessive contact between cellular organelles disrupts metabolism in obesity

For immediate release: November 24, 2014 Boston, MA – Researchers at Harvard School of Public Health (HSPH) have found a novel mechanism causing type…

N30 Pharma picks up $30M in mezzanine funding round to advance cystic fibrosis drug

N30 Pharmaceutials Inc. (Boulder), a clinical-stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced it raised $30 million in a mezzanine financing round.

Kevin M. Smith to Retire as President & CEO of CID4; Search Committee Formed to Hire Smith’s Successor

(Aurora) The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a search for a new Executive Director, as Kevin M. Smith leaves as part of a planned retirement.  Mr. Smith will remain with CID4 through February 2015 ...

Targeting Parkinson’s Disease Pathways

By blocking mitochondria division, scientists were able to restore function in mouse models of Parkinson’s disease. These preliminary findings suggest a strategy to slow or halt the disease.

New Drug for Common Liver Disease Assessed

An experimental drug showed promising results and potential problems in treating a common liver disease. The drug’s long-term effects still need to be assessed.

Gene Disruptions Associated with Autism Risk

Researchers identified mutations in 107 genes that may contribute to the risk for autism spectrum disorder. The findings may help lead to potential therapies.

CHMP nods several drugs through

Ten new medicines have been recommended for approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP), among them breakthrough IPF drug Ofev. Boehringer Ingelheim’s Ofev (nintedanib) is one of only two drugs currently available in the world for the treatment of idiopathic pulmonary fibrosis (IPF), a fatal lung diseases characterised by scarring of the lung tissue. read more

Gezielte Leberkrebs-Therapie: Ursache für Fehlschlag entdeckt

Mögliche Ursache für Fehlschlag gezielter Leberkrebs-Therapien entdeckt Das Scheitern experimenteller Leberkrebs-Therapien, die gezielt gegen das Protein EGFR gerichtet sind, hat seine Ursache vermutlich in einer zu wenig spezifischen Auswahl an Pa...

Brain abnormality found in group of SIDS cases

NIH-supported researchers find abnormality in brain area influencing breathing, heart functions.

Hichrom’s new 2015 LC, GC and sample preparation training courses from world-renowned experts

Hichrom's 2015 training programme is now available, featuring courses covering every area of HPLC, UHPLC, GC and sample preparation and delivered by world-renowned experts including John Dolan, Mel Euerby, Mark Powell, Diane Turner, Alan McKeown, Geoff Pickerell, Brian Montgomery, Helen Poole, Gemma Lo and Annette Larder. Whether you are a relative newcomer to chromatography or a seasoned veteran,...

Takeda: we’re working on Ebola too

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection of the Ebola virus. Rajeev Venkaya who is the US Chicago-based head of its vaccines business unit was asked if – like GSK, J&J, ZMapp and Sihuan pharma – Takeda too was working on anything to prevent the disease or its spread. Venkaya says: “We are lookin...

Hirschmann celebrate 50 years with anniversary editions of pipetus® and rotarus® smart

Hirschmann will celebrate a notable anniversary in 2014 to mark 50 years of use of Hirschmann products in laboratories around the world. The pipetus® product family will be supplemented by a special edition to mark the anniversary year along with the rotarus® peristaltic pump series pipetus® combines many years of experience, innovative technology and superior-quality materials. Chargi...

Advanced Selectivity Phases for Powerful UHPLC and HPLC Method Development

Advanced Chromatography Technologies’ range of Advanced Selectivity phases offers chromatographers an extremely powerful tool for UHPLC and HPLC method development. These phases incorporate the latest developments in LC stationary phase design to provide chromatographers with more choices for alternative selectivity but without compromising stability or robustness. ACE Advanced Selectivity p...

Sunday 23rd November 2014

MD Anderson researchers find novel regulatory mechanism for cell division

A protein kinase or enzyme known as PKM2 has proven to control cell division, potentially providing a molecular basis for tumor diagnosis and treatment.

Multiple biopsies are superior to a single biopsy in detecting cervical cancer precursors

Performing multiple biopsies during a procedure known as colposcopy—visual inspection of the cervix—is more effective than performing only a single biopsy of the worst-appearing area for detecting cervical cancer precursors. This multiple biopsy ...

Friday 21st November 2014

Innovenn Commences Production of Labskin at New State of the Art Facilities

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that its innovation division, Innovenn,...

Search BioPortfolio: